Know Cancer

or
forgot password

Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors


N/A
N/A
N/A
Not Enrolling
Both
Primary or Metastatic Central Nervous System (CNS) Tumor

Thank you

Trial Information

Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors


The main objective of the protocol is the establishment of a repository of central nervous
system (CNS) tumors or metastases to the CNS and related tissues as an invaluable resource
for current or future research studies of the etiology, pathogenesis and treatment of human
central nervous system tumors. The database will be established through the intra-operative
acquisition of brain or spine tumors as well as the collection of blood and spinal fluids
from consenting CNS tumor patients.


Inclusion Criteria:



- For acquisition of intra-operative brain or spine tumor specimens, blood specimens
and spinal fluid specimens, all patients who undergo surgery for resection or biopsy
qualify for inclusion in this protocol.

- If spinal fluid is not accessed as part of the operative procedure, it will not be
collected.

- All patients must be under the care of one or more members of the MSKCC CNS disease
management team at the time of tissue acquisition. Patients may have been previously
diagnosed and/or treated at another institution.

- Subjects are eligible regardless of sex, age or race.

- Parental or guardian consents will be obtained in the case of minors (less than 18
years of age)

Exclusion Criteria:

- Patients or their guardians, in case of a minor, may choose to be excluded at any
time.

- If a patient, or guardian, decides to withdraw after some or all of the tissues have
been collected, such tissues will be destroyed at their request.

- Patients or their guardians will be counseled at the time of obtaining their consent,
of the possibility of withdrawing from the protocol.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To establish a repository of CNS tumors or metastases to the CNS and related tissues for current or future studies.

Outcome Time Frame:

conclusion of the study

Safety Issue:

No

Principal Investigator

Philip Gutin, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

99-125

NCT ID:

NCT00580463

Start Date:

January 2000

Completion Date:

March 2009

Related Keywords:

  • Primary or Metastatic Central Nervous System (CNS) Tumor
  • central nervous system (CNS) tumor
  • tissue collection
  • Spinal Cord Neoplasms

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021